Best Growth Stocks to Buy

Companies compounding profit and revenue fast — the engine of long-term price gains.

Not investment advice

These lists are rules-based research, not buy recommendations. Rankings are generated from NSE & BSE data by a deterministic formula and do not account for your personal circumstances. For informational purposes only. Consult a SEBI-registered advisor before investing.

How we rank: We require net-profit growth > 20% and revenue growth > 15% year-on-year (market cap > ₹2,000 Cr), then rank by profit growth.
#1
2,235.5-2.25%Score 66/100
PAT YoY +7425.0%Rev YoY +15.8%ROE 30.5%Mkt Cap (Cr) 63,109
  • ROE of 31% — excellent capital efficiency
  • ROCE of 40% — highly efficient use of capital
  • Healthy ROE of 31%
  • Net profit up 7425% YoY
View full analysis
#2
18,434-1.69%Score 68/100
PAT YoY +660.7%Rev YoY +136.6%ROE 21.4%Mkt Cap (Cr) 23,643
  • ROE of 21% — excellent capital efficiency
  • ROCE of 27% — highly efficient use of capital
  • Healthy ROE of 21%
  • Net profit up 661% YoY
View full analysis
#3
1,865.4+1.19%Score 72/100
PAT YoY +657.4%Rev YoY +404.6%ROE 36.6%Mkt Cap (Cr) 1,04,970
  • ROE of 37% — excellent capital efficiency
  • ROCE of 27% — highly efficient use of capital
  • Healthy ROE of 37%
  • Net profit up 657% YoY
View full analysis
#4
1,693+3.12%Score 52/100
PAT YoY +579.1%Rev YoY +166.6%ROE 7.5%Mkt Cap (Cr) 72,899
  • Net profit up 579% YoY
  • Revenue up 167% YoY
  • In a confirmed uptrend (above 200-DMA, bullish Supertrend)
View full analysis
#5
1,900.7+1.29%Score 50/100
PAT YoY +464.4%Rev YoY +29.9%ROE 6.1%Mkt Cap (Cr) 30,883
  • Net profit up 464% YoY
  • Revenue up 30% YoY
  • In a confirmed uptrend (above 200-DMA, bullish Supertrend)
View full analysis
#6
1,025-0.29%Score 46/100
PAT YoY +442.4%Rev YoY +23.0%ROE 8.2%Mkt Cap (Cr) 1,04,575
  • Net profit up 442% YoY
  • Revenue up 23% YoY
View full analysis
#7
2,144.3-1.93%Score 39/100
PAT YoY +392.2%Rev YoY +20.0%ROE 0.9%Mkt Cap (Cr) 49,101
  • Net profit up 392% YoY
  • Revenue up 20% YoY
View full analysis
#8
6,436+0.93%Score 63/100
PAT YoY +361.3%Rev YoY +105.6%ROE 28.1%Mkt Cap (Cr) 20,055
  • ROE of 28% — excellent capital efficiency
  • ROCE of 26% — highly efficient use of capital
  • Healthy ROE of 28%
  • Net profit up 361% YoY
View full analysis
#9
286.6+0.05%Score 46/100
PAT YoY +346.2%Rev YoY +196.5%ROE 1.2%Mkt Cap (Cr) 2,76,717
  • Net profit up 346% YoY
  • Revenue up 196% YoY
  • In a confirmed uptrend (above 200-DMA, bullish Supertrend)
View full analysis
#10
213.17-5.00%Score 44/100
PAT YoY +321.7%Rev YoY +127.7%ROE 7.0%Mkt Cap (Cr) 32,686
  • Net profit up 322% YoY
  • Revenue up 128% YoY
  • In a confirmed uptrend (above 200-DMA, bullish Supertrend)
View full analysis
#11
323.05-0.55%Score 54/100
PAT YoY +315.8%Rev YoY +28.4%ROE 15.3%Mkt Cap (Cr) 92,164
  • Healthy ROE of 15%
  • Net profit up 316% YoY
  • Profit compounding 113% a year (3Y)
  • Revenue up 28% YoY
View full analysis
#12
153.17-1.54%Score 31/100
PAT YoY +303.4%Rev YoY +17.0%ROE 2.5%Mkt Cap (Cr) 17,539
  • Net profit up 303% YoY
  • Revenue up 17% YoY
View full analysis
#13
2,747.5-2.42%Score 64/100
PAT YoY +292.6%Rev YoY +205.5%ROE 56.3%Mkt Cap (Cr) 70,081
  • ROE of 56% — excellent capital efficiency
  • ROCE of 71% — highly efficient use of capital
  • Healthy ROE of 56%
  • Net profit up 293% YoY
View full analysis
#14
110.54-1.25%Score 66/100
PAT YoY +258.1%Rev YoY +37.5%ROE 45.7%Mkt Cap (Cr) 1,20,744
  • ROE of 46% — excellent capital efficiency
  • Healthy ROE of 46%
  • Net profit up 258% YoY
  • Revenue up 38% YoY
View full analysis
#15
520.4-3.87%Score 39/100
PAT YoY +247.5%Rev YoY +37.0%ROE 2.2%Mkt Cap (Cr) 26,020
  • Net profit up 248% YoY
  • Revenue up 37% YoY
View full analysis
#16
295.6-1.70%Score 58/100
PAT YoY +216.5%Rev YoY +31.4%ROE 17.5%Mkt Cap (Cr) 40,996
  • Healthy ROE of 18%
  • Net profit up 216% YoY
  • Profit compounding 38% a year (3Y)
  • Revenue up 31% YoY
View full analysis
#17
6,046-5.00%Score 50/100
PAT YoY +214.3%Rev YoY +67.2%ROE 12.6%Mkt Cap (Cr) 18,646
  • Net profit up 214% YoY
  • Revenue up 67% YoY
View full analysis
#18
3,614.4-4.88%Score 68/100
PAT YoY +207.3%Rev YoY +45.5%ROE 25.4%Mkt Cap (Cr) 42,618
  • ROE of 25% — excellent capital efficiency
  • ROCE of 30% — highly efficient use of capital
  • Healthy ROE of 25%
  • Net profit up 207% YoY
View full analysis
#19
34,870-1.62%Score 66/100
PAT YoY +202.8%Rev YoY +16.8%ROE 30.0%Mkt Cap (Cr) 39,275
  • ROE of 30% — excellent capital efficiency
  • ROCE of 50% — highly efficient use of capital
  • Healthy ROE of 30%
  • Net profit up 203% YoY
View full analysis
#20
214.78+0.85%Score 69/100
PAT YoY +200.0%Rev YoY +116.4%ROE 27.3%Mkt Cap (Cr) 29,353
  • ROE of 27% — excellent capital efficiency
  • ROCE of 34% — highly efficient use of capital
  • Healthy ROE of 27%
  • Net profit up 200% YoY
View full analysis

About this list

Rising earnings drive share prices over time. This list ranks companies growing both their top and bottom lines quickly — where durable, the compounding can be powerful.

Important caveat

Fast growth usually comes with a rich valuation, and a single strong year can be a base effect. Check the PEG ratio and whether the growth is sustainable.

Build your own screen
Full screener with 20+ fundamental & technical filters.
High Growth Stocks
The full screen behind this list.
Understand the PEG Ratio
The key ratio behind this ranking.

More best-stock lists

All best-stock lists →

For informational purposes only, not investment advice. Data from NSE & BSE feeds; rankings are rules-based, not recommendations. Consult a SEBI-registered advisor before investing.